-
immunotherapies. The main focus of the proposed project is to explore new combinatorial epigenetic therapies to treat blood cancers. The position is funded by the Fondation ARC under the 2023 ‘Recruiting
-
). The functional optimization of T lymphocytes used for these immunotherapy strategies is now at the forefront of our current preoccupations. In this context, recent advances in T cell biology, molecular modulation
-
, electrical, or electromagnetic) to optimize the robustness and reproducibility of the regenerative process. The project will integrate advanced biofabrication approaches, such as 3D bioprinting and the
-
subsets in cancer immunity and immunotherapy. We will develop a research topic focusing on innovative cancer vaccine (T helper vaccine, mRNA…), optimized CAR-T approaches (introduction of a new companion